Home Your basket
• Reconstruction of bone de...
   Price 10.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Is coincidence detection ...
   Price 10.50 €
• Objective tinnitus and es...
   Price 5.50 €
• Reconstruction after tumo...
   Price 10.50 €
• The emergency in the mana...
   Price 10.50 €
• Cervical surgical emphyse...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Unilateral frontal sinus ...
   Price 8.50 €
• Correlation between laryn...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• Thyroid tuberculosis asso...
   Price 5.50 €
• Feasibility study of sept...
   Price 10.50 €
• Paranasal sinus mucoceles...
   Price 14.00 €
• Facial threads for face l...
   Price 10.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Evolution of facial nerve...
   Price 10.50 €
• The role of larynx kinest...
   Price 10.50 €
• Management of labial inco...
   Price 10.50 €
• Training strategies of th...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• Learning curve in sialend...
   Price 10.50 €
• A study of the effects of...
   Price 14.00 €
• Patient preference survey...
   Price 10.50 €
• Different clinical approa...
   Price 5.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• Solitary myofibroma of th...
   Price 5.50 €
• Lysis of the incus long p...
   Price 10.50 €
• Contribution of clinical ...
   Price 14.00 €
• Vertigo and pathology of ...
   Price 10.50 €
• Artistic anatomy of the n...
   Price 8.50 €
• Acute rhinosinusitis in a...
   Price 8.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Melanotic neuroectodermal...
   Price 8.50 €
• Management of peritonsill...
   Price 5.50 €
• Cholesterol granuloma of ...
   Price 8.50 €
• Association of Bezold’s a...
   Price 8.50 €
• Oncocytoma of the parotid...
   Price 8.50 €

Total Order 372.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE